133 related articles for article (PubMed ID: 2468796)
1. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients.
Stamey TA; Kabalin JN; Ferrari M
J Urol; 1989 May; 141(5):1084-7. PubMed ID: 2468796
[TBL] [Abstract][Full Text] [Related]
2. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
Stamey TA; Kabalin JN; McNeal JE; Johnstone IM; Freiha F; Redwine EA; Yang N
J Urol; 1989 May; 141(5):1076-83. PubMed ID: 2468795
[TBL] [Abstract][Full Text] [Related]
3. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients.
Stamey TA; Kabalin JN
J Urol; 1989 May; 141(5):1070-5. PubMed ID: 2468794
[TBL] [Abstract][Full Text] [Related]
4. Prostate specific antigen levels after definitive irradiation for carcinoma of the prostate.
Schellhammer PF; Schlossberg SM; el-Mahdi AM; Wright GL; Brassil DN
J Urol; 1991 May; 145(5):1008-10; discussion 1010-1. PubMed ID: 1707987
[TBL] [Abstract][Full Text] [Related]
5. The value of serum prostate specific antigen determinations before and after radical prostatectomy.
Lange PH; Ercole CJ; Lightner DJ; Fraley EE; Vessella R
J Urol; 1989 Apr; 141(4):873-9. PubMed ID: 2467013
[TBL] [Abstract][Full Text] [Related]
6. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients.
Stamey TA; Kabalin JN; Ferrari M; Yang N
J Urol; 1989 May; 141(5):1088-90. PubMed ID: 2468797
[TBL] [Abstract][Full Text] [Related]
7. The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate.
Maatman TJ
J Urol; 1989 Jun; 141(6):1378-80. PubMed ID: 2470927
[TBL] [Abstract][Full Text] [Related]
8. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.
Zagars GK
J Urol; 1994 Nov; 152(5 Pt 2):1786-91. PubMed ID: 7523725
[TBL] [Abstract][Full Text] [Related]
9. Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy.
Schellhammer PF; el-Mahdi AM; Higgins EM; Schultheiss TE; Ladaga LE; Babb TJ
J Urol; 1987 May; 137(5):897-901. PubMed ID: 3106654
[TBL] [Abstract][Full Text] [Related]
10. PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure.
Ko EC; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):600-7. PubMed ID: 21985944
[TBL] [Abstract][Full Text] [Related]
11. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen after irradiation for prostatic carcinoma.
Kaplan I; Prestidge BR; Cox RS; Bagshaw MA
J Urol; 1990 Nov; 144(5):1172-5; discussion 1175-6. PubMed ID: 1700144
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer.
Mannini D; Maver P; Aiello E; Corrado G; Vecchi F; Bellanova B; Marengo M
Urol Res; 1988; 16(1):9-12. PubMed ID: 2449758
[TBL] [Abstract][Full Text] [Related]
14. The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients.
Stamey TA; Ferrari MK; Schmid HP
J Urol; 1993 Dec; 150(6):1856-9. PubMed ID: 7693982
[TBL] [Abstract][Full Text] [Related]
15. Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen levels.
Dugan TC; Shipley WU; Young RH; Verhey LJ; Althausen AF; Heney NM; McManus PL; Abraham EH
J Urol; 1991 Nov; 146(5):1313-6. PubMed ID: 1719244
[TBL] [Abstract][Full Text] [Related]
16. Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen.
Kabalin JN; Hodge KK; McNeal JE; Freiha FS; Stamey TA
J Urol; 1989 Aug; 142(2 Pt 1):326-31. PubMed ID: 2473221
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen. Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor marker.
Dundas GS; Porter AT; Venner PM
Cancer; 1990 Jul; 66(1):45-8. PubMed ID: 1693877
[TBL] [Abstract][Full Text] [Related]
18. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen Z; Lief JH; Adamovich E
Urology; 2005 Jan; 65(1):95-100. PubMed ID: 15667872
[TBL] [Abstract][Full Text] [Related]
19. Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy.
Eggener SE; Roehl KA; Yossepowitch O; Catalona WJ
J Urol; 2006 Oct; 176(4 Pt 1):1399-403. PubMed ID: 16952643
[TBL] [Abstract][Full Text] [Related]
20. [Long-term follow-up of serum prostate-specific antigen after radiotherapy of prostatic carcinoma].
Schmid HP; Ferrari MK; Stamey TA
Helv Chir Acta; 1994 Dec; 60(6):1101-5. PubMed ID: 7533148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
